Your AI-Trained Oncology Knowledge Connection!

Exploring Advanced Renal Cell Carcinoma: Expert and Patient Perspectives : Episode 9

A Patient’s Experience With Managing Side Effects of Treatment for Advanced RCC

December 28, 2023

By Thomas E. Hutson, DO, PharmD
Kacie Ellis, RN

Opinion

Video

A patient's perspective on managing the side effects of treatment for advanced RCC.

EP: 1.Overview of Renal Cell Carcinoma (RCC)

EP: 2.Diagnosis and Risk Stratification of Patients With RCC

EP: 3.A Patient’s Experience With an RCC Diagnosis

EP: 4.Navigating a Diagnosis of RCC

EP: 5.The Role of Registered Nurses in the Multidisciplinary Treatment of Advanced RCC

EP: 6.A Patient’s Experience With Initial Treatment for RCC

EP: 7.Overview of the Systemic Treatment Options for Advanced RCC

EP: 8.Educating Patients With Advanced RCC on Side Effects of Available Combination Therapies

EP: 9.A Patient’s Experience With Managing Side Effects of Treatment for Advanced RCC

EP: 10.Future Perspectives in the Management of RCC

EP: 11.Advice for Patients Living With RCC

EP: 12.Patient's Perspective on Pembrolizumab/Lenvatinib Use in RCC

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos

Blood-based markers of note in kidney cancer prognosis include circulating tumor DNA and proteomic markers, according to Michael B. Atkins, MD.

Clinical trials still have a role in improving outcomes with immunotherapy among those with kidney cancer.

Current research initiatives in the kidney cancer field include exploring anti–PD-1, anti–LAG-3, and anti–CTLA-4 combination regimens.

OncNursingNews.com

TargetedOnc.com

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

259 Prospect Plains Rd, Bldg H,
Monroe, NJ 08831

© 2025 MJH Life Sciences

All rights reserved.